Abstract The purpose of this investigation was to evaluate a rapid quantitative real-time polymerase chain reaction (PCR) for the direct detection and quantification of pneumococcal DNA bacterial load (DBL) in patients with pneumonia and empyema. DBL and molecular serotype detection was determined by DNA quantification of the pneumolysin (ply) gene and an additional capsular gene by real-time PCR. Plasma or pleural fluid samples from children and adolescents with confirmed pneumococcal pneumonia were analyzed. DBL was correlated with clinical parameters and outcomes. One hundred and sixtynine patients with pneumococcal pneumonia (145 empyema) had bacterial cultures and real-time PCR assays performed. Among them, 41 (24.3%) had positive results for both, 4 (2.4%) had positive culture alone, and 124 (73.3%) had positive real-time PCR alone. The pleural fluid DBL was lower in patients with prior antibiotics (p=0.01) and higher in patients with positive culture (p<0.001). The pleural fluid DBL was positively correlated with serum C-reactive protein (p=0.009), pleural fluid neutrophils (p<0.001), and pleural fluid glucose (p <0.001). The plasma and pleural fluid DBL were higher in patients with ≥8 days of hospital stay (p=0.002), and the pleural fluid DBL was positively correlated with the number of hours of pleural drainage (p<0.001). Quantification of pneumococcal DBL by real-time PCR may be helpful for the diagnosis and clinical management of pediatric patients with pneumonia and empyema
Introduction
Streptococcus pneumoniae is one of the major bacterial pathogens causing severe infections with high morbidity and mortality [1] . There are 93 pneumococcal capsular types (serotypes), but only a limited number of them cause the majority of invasive pneumococcal disease (IPD) [2] .
The gold standard culture-based method for the diagnosis of IPD requires the isolation and identification of Streptococcus pneumoniae from normally sterile clinical specimens; it needs up to 48-72 h to confirm the results and may have a low sensitivity [3] .
It is well known that many febrile children who are seen at the Emergency Department had received prior antibiotics and it can prevent the growth of Streptococcus pneumoniae in cultures [4] . Therefore, several episodes of infection caused by antibiotic-susceptible pneumococcal serotypes may be misdiagnosed and, consequently, the rates of IPD can be underestimated. In order to improve the diagnosis of IPD and also to perform valuable epidemiological surveillance studies, we need additional methods with higher sensitivity and which can be carried out in a shorter period of time than the standard culture-based method.
Molecular techniques applied to quantify viral load are widely accepted for monitoring the course of infections such as hepatitis C or human immunodeficiency virus (HIV) [5] [6] [7] [8] . However, little is known about the usefulness of the direct detection and quantification of pneumococcal DNA in patients with IPD. Current molecular techniques such as pneumococcal real-time polymerase chain reaction (PCR) (direct detection of pneumococcal DNA) may be rapid methods to improve the diagnosis of IPD and also for serotyping. Moreover, real-time PCR may allow determining the quantification of pneumococcal DNA bacterial load (DBL) in different clinical samples and improving the management of patients with IPD, such as those which occur in some viral infections [9, 10] . To our knowledge, there are no reports about the plasma and pleural fluid DBL in children with pneumonia and empyema.
The objectives of this study were: (1) to evaluate a rapid quantitative real-time PCR for the direct detection and quantification of pneumococcal DBL in sterile clinical samples, and (2) to examine the relationship between DBL (in plasma and pleural fluid) with several clinical and microbiological variables in children with pneumonia and empyema.
Patients and methods
We prospectively studied all children and adolescents (less than 18 years of age) with confirmed pneumococcal pneumonia who attended the Sant Joan de Deu Hospital, a 345-bed children's hospital in Barcelona, Spain, from 6/ 2003 to 6/2008.
Confirmed pneumococcal pneumonia was defined as the presence of clinical and radiological findings of pneumonia, together with the isolation of Streptococcus pneumoniae and/or DNA detection of Streptococcus pneumoniae by real-time PCR in plasma and/or pleural fluid. Plasma and/ or pleural fluid samples were obtained when available and according to patients' symptoms. For the present study, we have selected those children with confirmed pneumococcal pneumonia who had been studied by both culture and real-time PCR.
As a control group, the real-time PCR assay was assessed with 106 plasma samples from healthy individuals, 50 of whom were healthy nasopharyngeal carriers of Streptococcus pneumoniae. Blood samples were extracted in the outpatient's clinic prior to a minor surgical procedure (such us ocular surgery, phimosis, or non-complicated hernia) and after written informed consent was obtained.
Microbiological bacterial cultures
All pneumococcal isolates were identified by standard microbiological methods as previously described [11, 12] .
Serotype identification
The serotyping of strains isolated by culture was carried out by the Quellung reaction at the National Center for Microbiology (Majadahonda, Madrid, Spain). The detection of pneumococcal serotypes in clinical samples with negative culture were performed in our laboratory according to multiplex real-time PCR [13] . This sequential PCR approach distinguishes among 24 serotypes (1, 3, 4, 5, 6A, 6B, 7F/A, 8, 9V/A/N/L, 14, 15B/C, 18C/B, 19A, 19F/B/C, 23A, and 23F). Serotypes were classified into two groups: PCV7 serotypes (4, 6B, 9V, 14, 18C, 19F, and 23F) and non-PCV7 serotypes including all others.
Extraction of DNA
The DNA of pneumococci in sterile samples was extracted using 20% w/v Chelex-100 resin (BioRad Laboratories, Hercules, CA, USA). Plasma and pleural fluid samples required previous preparation as follows: 200 μl of samples were centrifuged at 4°C and 25,000g for 60 min. After removal of the supernatant, samples were resuspended in 100 μl of PBS buffer. Then, 50 μl of prepared samples were added and vortexed with 150 μl of 20% w/v Chelex-100. The tubes were incubated for 20 min at 56°C followed by a 10-min incubation at 99°C. After cooling, the supernatant was used as a template in the real-time PCR experiments.
DNA from samples collected since 2006 were extracted from 200 μl of biological fluid (plasma, pleural fluid) by an automated system for DNA extraction (easyMAG, bioMérieux Laboratories). Selected samples were performed in parallel in order to compare the recovery of bacterial DNA using both DNA extraction methods.
DNA quantification by the real-time PCR assay
TaqMan fluorescent probes and specific primers for the pneumolysin (ply) gene of Streptococcus pneumoniae (GenBank accession no. MX52474) [14] that have been previously described by Corless et al. were used [15] . In addition, these primer sets were tested using the Primer Express 2.0 software (Applied Biosystems, Foster City, CA, USA) for universal conditions of amplification. Amplification was done in a real-time PCR instrument ABI PRISM 7000 (Applied Biosystems, Foster City, CA, USA). The reaction volume of 25 μl contained 5 μl of DNA extract from samples or controls and 2× TaqMan Universal Master Mix (Applied Biosystems), which includes dUTP and uracil-N-glycosylase; each primer was used at a final concentration of 300 nM. The TaqMan probe was used at a final concentration of 150 nM. Internal controls for monitoring false-negatives by PCR inhibitors were run for each sample to monitor the overall assay performance, and these consisted of 1 μl of TaqMan RNase P Control Reagent (VIC) (Applied Biosystems, Foster City, CA, USA) that included human RNase P primers and the TaqMan Probe with VIC as the fluorescent reporter dye at the 5′ end. Amplification was performed using universal amplification conditions: incubation for 2 min at 50°C (uracil-N-glycosylase digestion) and 10 min of denaturation at 95°C, 45 cycles of two-step amplification (15 s at 95°C and 60 s at 60°C). The amplification data were analyzed by SDS Software (Applied Biosystems). The reporter dye (FAM for samples or VIC for the internal control) signal was measured relative to the internal reference dye (ROX) signal to normalize for non-PCR-related fluorescence fluctuations occurring from well to well. The cycle threshold (C T ) value was defined as the cycle at which the reporting dye fluorescence first exceeds the calculated background level. A low C T value thus corresponds to a high target concentration. The quantification of Streptococcus pneumoniae in each sample was based on a standard curve generated by plotting the C T value against known genomic equivalents.
Determination of PCR efficiency and the calibration curve for DNA quantification A 0.5 McFarland suspension was made from a serotype 19F Streptococcus pneumoniae strain obtained from our bacteriological laboratory and serial dilutions from 1.7 ng/ μl (7 × 10 7 CFU/mL) to 0.6 fg/μl (7 CFU/mL) were performed. These serial dilutions were used to generate a reference standard curve which was exported and used as an external standard curve after each run. The external standard curve was calibrated with two standard controls included in each run with the clinical samples. DNA extraction of these serial dilutions was performed by using a manual method and the easyMAG platform.
The reproducibility of triplicate C T values was assessed on all standard specimens. The mean intra-assay and interassay coefficient of variation were calculated from the C T values.
Statistical analysis
Statistical analysis was performed with the PASW software package (version 17.0). Pneumococcal DBL data were logtransformed to assume a normal distribution. Continuous variables were compared using the t-test (for approximately normally distributed data) or the Mann-Whitney U-test (for skewed data) and are described as mean values and standard deviations or median and interquartile range (IQR; 25th-75th percentiles) according to the presence of normal distribution, respectively. The Chi-square test or Fisher's exact test (twotailed) were used to compare categorical variables. Associations between routine biochemical variables and DBL were examined using Spearman's correlation coefficient. Comparison between groups was performed by the Kruskal-Wallis test. Logistic regression models were used to examine the independent effect of DBL on the length of hospital stay after adjusting for other variables. Statistical significance was set at a p-value of <0.05.
Results
Overall, there were 206 children with confirmed pneumococcal pneumonia and we included in the study 169 children (145 with empyema and 24 without empyema) who had both bacterial cultures and real-time PCR performed. Of them, 41 (24.3%) had both positive culture and real-time PCR, 4 (2.4%) had positive culture and negative real-time PCR, and 124 (73.3%) had positive realtime PCR and negative culture.
Reproducibility and specificity of the real-time PCR assay
The real-time PCR assay detected correctly all serial dilutions (range 7 to 7 × 10 7 CFU copies/mL). There was a linear correlation between the log of the standards and the threshold cycles (C T ), with a regression line showing a slope of −3.5 and a Pearson correlation coefficient of 0.99 when DNA extraction was made by the Chelex-100 method or by the easyMAG method. The amount of PCR product formed was derived from the function y=−3.5x+29.4 for the Chelex method and y=−3.5x+32.2 for easyMAG method. The reproducibility was calculated using the standard curve that was amplified in three consecutive runs using the manual method and the easyMAG method. The standard deviation of the mean C T was always less than one cycle for the two procedures.
The real-time PCR was highly specific; only two of the 106 plasma samples from healthy children were positive by real-time PCR, and they had a low pneumococcal DBL (5 and 2 CFU copies/mL, respectively). Of note, one of these two children was a pneumococcal nasopharyngeal carrier and the other was, presumably, a non-identified carrier.
Pneumococcal DBL and clinical characteristics
There were 165 children with pneumonia and positive detection of pneumococcal DNA in sterile samples (one or more). Pleural fluid was positive in 126 of 129 samples collected (97.6%) and plasma was positive in 85 of 137 (62%) samples. Among 145 children with empyema, plasma and pleural fluid were analyzed in 101, and 52 (51.5%) were positive for pleural fluid only, 3 (3%) were positive for plasma only, and 46 (45.5%) were positive for both.
Overall, there were 89 males (53.9%), and the mean age was 54.2 months (standard deviation [SD] 38.8 months) (range 1 month to 17 years). According to the criteria of the American Academy of Pediatrics [16] , 9 patients (6.2%) had risk factors for IPD as follows: chronic pulmonary disease 6, chronic cardiac disease 2, and measles coinfection 1. Prior vaccination with PCV7 was detected in 42 of 150 patients (28%) who had available information, and all of them were infected by non-vaccine serotypes. The mean number of hours of fever before admission (in 161 cases) were 107.5 hours (SD 64 hours). Prior antibiotics were identified in 84 of 153 patients (54.9%) who had available information. Of the 165 pneumococcal pneumonia cases, 126 were serotyped (76.3%) (41 by conventional serotyping in culture-positive samples and 85 by multiplex realtime PCR in culture-negative samples); sufficient material for serotyping was not available in 39 patients. Of the 126 episodes with serotype information, 10 (7.9%) were caused by vaccine serotypes and 116 (92.1%) by non-vaccine serotypes. The main serotypes detected were serotype 1 (53 patients; 42%), serotype 19A (16 patients; 12%) , serotype 3 (11 patients; 8.7%), 7F (11 patients; 8.7%), and serotype 5 (6 patients; 4.7%). Fourteen of 165 patients (8.5%) were admitted to the pediatric intensive care unit (PICU). The mean length of hospital stay was 11.4 days (SD 6.5 days). None of the patients died.
As shown in Fig. 1 , the pneumococcal DBL was much higher in pleural fluid than in plasma (Mann-Whitney test, p<0.001). According to the clinical syndrome, the plasma DBL was slightly higher in patients with pneumonia and empyema (n=65) than in patients with non-complicated pneumonia (without empyema) (n=20): bacterial load median log 10 CFU copies/mL (IQR): 1.14 (0.44-1.59) versus 0.97 (0.55-1.15), but it did not reach statistical significance (Mann-Whitney test, p=0.4). Table 1 shows the plasma and pleural fluid DBL according to several parameters. Most clinical and microbiological variables were not associated with differences in the plasma DBL. However, the plasma DBL was significantly higher in patients with ≥8 days of hospital stay as compared with those with <8 days of stay ( Table 1) .
As shown in Table 1 , the pleural fluid DBL was lower in patients with prior antibiotic therapy (as compared with no prior antibiotics) (p=0.01), and was higher in those with positive culture for Streptococcus pneumoniae (as compared with negative cultures) (p<0.001). In addition, as occurred in plasma DBL, there were higher levels of pleural fluid DBL in patients with ≥8 days of hospital stay as compared with those with ≤7 days. Using multiple logistic regression models, we found that the plasma DBL (adjusted odds ratio [OR] 3.53; 95% confidence interval [CI]: 1.43-8.70; p=0.006) and the pleural fluid DBL (adjusted OR 1.46; 95% CI: 1.09-1.96; p=0.01) were independently associated with prolonged hospital stay (≥8 days) after adjusting for age, hours of fever before admission, and positive bacterial culture. Figure 2 shows a positive correlation between the pleural fluid DBL and the number of days spent in the hospital (Spearman's rho: 0.4; p<0.001) and the total number of hours of pleural drainage (Spearman's rho: 0.4; p<0.001).
As shown in Fig. 3 , the pleural fluid DBL showed a positive correlation with the plasma DBL (Spearman's rho: 0.3; p<0.01). In addition, the pleural fluid DBL had a significant correlation with several biochemical markers of infection, such as serum C-reactive protein (CRP) (Spearman's rho: 0.2 ; p =0.009), pleural fluid neutrophils (Spearman's rho: 0.4; p<0.001), and pleural fluid glucose levels (Spearman's rho: −0.8; p<0.001).
Discussion
DNA detection and quantification may provide useful epidemiological and clinical information and improve our knowledge about the dynamics of pneumococcal replication. Two major findings are highlighted in this study. First, the significant increase of detecting pneumococcal pneumonia and empyema in children and subsequent serotyping To date, the reported studies on the use of PCR for the diagnosis of IPD have shown controversial results. Recently, Avni et al. [17] published an accurate meta-analysis and found that the studies were highly heterogeneously including different types of PCR methods [18, 19] , different target genes [20] , most used stored frozen [21] and different samples (i.e., whole blood or plasma) [22] , as well as different patient characteristics and different clinical syndromes [23, 24] . The authors concluded that "the lack of appropriate reference standard might have caused underestimation of the performance of the PCR" and that "currently available methods for PCR with blood samples for the diagnosis of IPD lack the sensitivity and specificity necessary for clinical practice."
In our study, we used fresh plasma and pleural fluid samples for the detection and quantification of the DNA and, in most cases, we have added the identification of serotypes by a multiplex real-time PCR, which allowed us DBL in plasma was studied in 85 of the 165 patients with pneumonia with and without empyema and DBL in pleural fluid was studied in 126 of the 145 patients with empyema IQR, interquartile range; the Mann-Whitney U-test was used for skewed data and unpaired Student's t-test was used for approximately normally distributed data to increase significantly the number of confirmed episodes with respect to the culture-based method, as occurred in the study reported by Azzari et al. [19] . Moreover, in the metaanalysis by Avni et al. [17] , the rate of diagnosis by positive PCR was also higher than the rate by positive blood culture in 16 of 25 studies. Some authors have warned of reporting IPD by PCR only because of the possibility of detecting false-positive results in blood samples of healthy children [25] . In our study, we used plasma samples and found a good specificity (only two samples of 106 tested from healthy controls). Of note, the worst specificity was found when using buffy coat as the blood sample [26] instead of plasma samples. One limitation of our study is that we used the ply gene for the detection (diagnosis) and quantification of pneumococcal DBL. The ply gene may be unspecific because some other strains closely related with Streptococcus pneumoniae may share the virulent genes encoding by Streptococcus pneumoniae, such as ply or lytA genes [27] . Carvalho Mda et al. [20] tested two ply-based PCR assays against 10 Streptococcus pseudopneumoniae isolates and 11 isolates of pneumococcus-like viridans group streptococci (P-LVS) and found a positive reaction in all of them. However, we may consider that, in our study, the consecutive serotyping by real-time PCR (which included testing with capsular genes of pneumococci) and the detection of a virulent gene (the ply gene) of pneumococci in sterile samples of patients with clinical symptoms and radiologically confirmed pneumonia and empyema may have significant clinical value. To date, the clinical role of Streptococcus pseudopneumoniae and other quasipneumococcus in invasive disease is unknown, but some authors have warned about the increase of these strains in the nasopharynx [28] . So, the clinical role of these closely related pneumococcal strains isolated in sterile samples need to be clarified.
In our study, the pleural fluid DBL was higher than the plasma DBL, and there was a positive correlation between both of them. Plasma DBL levels were not significantly associated with age, sex, underlying conditions, and other clinical and microbiological variables, but was higher in children who had Q8 days of hospital stay (Table 1) . A low level of plasma DBL was also found in other studies performed by culture-based methods [29] or by real-time PCR [30, 31] , and this may explain, at least in part, the low rate of positive blood cultures detected and the poor correlation of blood culture results with DBL (the plasma DBL was similar in children with positive and negative blood cultures). It is probably that the main factor for detecting pneumococci in blood culture-based methods (or by PCR-based methods) is related to the volume of sample processed, and in younger children, the blood volume is usually very low (approximately 1-2 ml in children less than 6 months of age or 2-5 ml in children between 6 months and 5 years of age). On the contrary, the pleural fluid DBL was highly correlated with the pleural fluid culture results (the pleural fluid DBL was significantly higher in cases with positive pleural fluid culture than in negative samples). It may be related to the inoculated volume for pleural fluid culture (approximately 5-10 ml of pleural fluid sample), which is usually higher than in blood cultures. However, the pleural fluid DBL levels were still high in patients with negative pleural fluid culture, and this may suggest that other factors should explain the low rate of positive culture in this type of sample. One may speculate that pleural fluid samples are usually sent to the laboratory in a sterile tube without transport medium, and this may be critical to reach a viable number of bacteria for culture. Our data Some studies have reported that prior antibiotics may affect the sensitivity of PCR assays [23, 32] , while others did not [22, 33] . In our study, we have found that the plasma DBL was very low and not significantly different between those with prior and no prior antibiotics, but the pleural fluid DBL was higher in those with no prior antibiotics ( Table 1 ). There were no significant differences in the plasma and pleural DBL levels between patients infected with PCV7 serotypes versus non-vaccine serotypes. However, it should be noted that several serotypes are included in each group and the low number of each specific serotype precluded further analyses. Positive correlations were observed for the pleural fluid DBL with plasma DBL, as well as with several routine hematological and biochemical parameters, such as serum CRP, pleural fluid neutrophils, and pleural fluid glucose levels.
Regarding the outcomes, both the plasma and pleural fluid DBL levels were higher in patients who had Q8 days of hospital stay (Table 1) . We could not correlate the DBL with mortality because none of our children died. Our data are in accordance with previous reports showing a relationship between DBL and worse outcome [10, 34] and prolonged length of hospital stay [9] in patients with severe pneumococcal infections, such as pneumonia and meningitis; as well as that occurred in patients with meningococcal meningitis in whom there was an association between bacterial load and mortality, complications, sequelae, and length of hospital stay [35] .
We found that, in our study children, the pleural fluid DBL was correlated with the number of hours of drainage (length of pleural drainage) (Fig. 1) . The treatment of pneumococcal empyema in children may be controversial, and recent studies have suggested that an early use of surgery with video-assisted thoracoscopy is associated with lower in-hospital mortality, length of hospital stay, and duration of antibiotic therapy, compared with a non-surgical group [36] . However, a pediatric surgeon may not always be available in all hospitals. These data suggest that the pleural fluid DBL (high levels) could help in the management of children with pleural pneumococcal empyema, and further studies are needed to evaluate this hypothesis.
In conclusion, the quantification of pneumococcal DBL by real-time PCR may be helpful for the diagnosis and clinical management of pediatric patients with pneumonia and empyema.
